GO:0046167 glycerol-3-phosphate biosynthetic process: Lipid Precursor Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046167 describes the biochemical reactions that produce glycerol-3-phosphate, a central phosphoric monoester of glycerol used for lipid synthesis.
• The pathway is essential for triacylglycerol and phospholipid production, and its flux is linked to metabolic stress, senescence, and cancer progression.
• Key enzymes include cytosolic GPD1 and mitochondrial GPD2, which form the glycerol-3-phosphate shuttle, and GPD1L, which supports lipid synthesis in tumors.
• Glycerol-3-phosphate accumulation can act as a signaling molecule that activates ChREBP and FGF21 transcription in citrin deficiency.
• In chronic kidney disease, glycerol-3-phosphate contributes to increased FGF23 production, linking this pathway to mineral bone disorders.
• CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the causal roles of glycerol-3-phosphate biosynthetic genes in disease.
Description
Glycerol-3-phosphate (G3P) is a simple three-carbon molecule that serves as the backbone for all glycerophospholipids and triacylglycerols. The Gene Ontology term GO:0046167, glycerol-3-phosphate biosynthetic process, defines the set of chemical reactions and pathways that result in the formation of this key metabolite. In eukaryotic cells, G3P is produced mainly by the reduction of dihydroxyacetone phosphate (DHAP) in a reaction catalyzed by cytosolic glycerol-3-phosphate dehydrogenase 1 (GPD1) and mitochondrial GPD2, which together constitute the glycerol-3-phosphate shuttle. This shuttle is not only a metabolic conduit but also a source of mitochondrial reactive oxygen species (ROS) that stabilize HIF-1α in neutrophils. Beyond its role in energy metabolism, G3P is now recognized as a signaling molecule. For example, in citrin deficiency, elevated G3P activates the transcription factor ChREBP and drives FGF21 expression and lipogenesis. In chronic kidney disease, G3P contributes to increased FGF23 production, a hormone that regulates phosphate homeostasis. These findings highlight that the glycerol-3-phosphate biosynthetic process is a critical node linking intermediary metabolism, lipid synthesis, and cellular signaling. Researchers studying this pathway need robust experimental models to determine how specific genes and mutations affect G3P levels and downstream phenotypes. This article provides a comprehensive overview of the pathway, its key genes, regulatory mechanisms, disease associations, and state-of-the-art research methods, including CRISPR-based genome editing.
glycerol-3-phosphate biosynthetic process At A Glance
| GO ID | GO:0046167 |
|---|---|
| GO term | glycerol-3-phosphate biosynthetic process |
| Ontology | biological_process |
| Synonym | glycerol-3-phosphate anabolism; glycerol-3-phosphate biosynthesis; glycerol-3-phosphate formation; glycerol-3-phosphate synthesis |
| Major function | Production of glycerol-3-phosphate for glycerophospholipid and triacylglycerol synthesis, and participation in the glycerol-3-phosphate shuttle |
| Key enzymes | GPD1, GPD2, GPD1L, glycerol kinase (GK) |
| Subcellular locations | Cytosol and mitochondria (shuttle components) |
| Related pathways | Glycolysis, gluconeogenesis, lipid metabolism, oxidative stress response |
What Is GO:0046167?
The glycerol-3-phosphate biosynthetic process (GO:0046167) encompasses the chemical reactions and pathways that lead to the formation of glycerol-3-phosphate, a phosphoric monoester of glycerol. This process includes both the direct phosphorylation of glycerol by glycerol kinase and the reduction of dihydroxyacetone phosphate (DHAP) by glycerol-3-phosphate dehydrogenase. It is a fundamental metabolic route for producing the glycerol backbone required for glycerolipid biosynthesis.
Why Is glycerol-3-phosphate biosynthetic process Important in Cell Biology?
The glycerol-3-phosphate biosynthetic process is essential for cellular lipid homeostasis and energy metabolism. It provides the glycerol backbone for the synthesis of triacylglycerols and phospholipids, which are required for membrane biogenesis and energy storage. Beyond its biosynthetic role, G3P acts as a signaling molecule that can influence gene expression, as shown by its activation of ChREBP and FGF21 in citrin deficiency. The pathway also contributes to mitochondrial ROS production via the glycerol-3-phosphate shuttle, which affects HIF-1α stability and immune cell function. Dysregulation of G3P metabolism is implicated in cancer, metabolic disorders, and chronic kidney disease, making it a compelling target for therapeutic intervention and a focus of active research.
• Provides the glycerol backbone for all glycerophospholipids and triacylglycerols, essential for membrane integrity and energy storage.
• The glycerol-3-phosphate shuttle transfers reducing equivalents from cytosol to mitochondria and modulates ROS production.
• G3P accumulation triggers senescence by rewiring lipid metabolism, linking the pathway to aging and age-related diseases.
• In citrin deficiency, G3P activates ChREBP and FGF21, driving lipogenesis and metabolic remodeling.
• G3P contributes to elevated FGF23 in chronic kidney disease, affecting phosphate and vitamin D metabolism.
• Cytosolic GPD is essential for lipid synthesis in kidney cancer, highlighting a role in tumor metabolism.
• GPD1L supports G3P and triacylglycerol synthesis and promotes tumor progression in hepatocellular carcinoma.
• Plant-associated bacteria sense G3P as a host signal, indicating its role in inter-kingdom interactions.
• The pathway is a potential target for treating metabolic disorders, cancer, and kidney disease.
• Understanding G3P biosynthesis aids in engineering lipid production in plants and microbes.
What Happens During glycerol-3-phosphate biosynthetic process?
Synthesis via DHAP reduction
In simple terms: The cell converts a glycolysis intermediate into glycerol-3-phosphate using a dehydrogenase enzyme.
The primary route for glycerol-3-phosphate (G3P) biosynthesis in many cells is the reduction of dihydroxyacetone phosphate (DHAP) by NADH-dependent glycerol-3-phosphate dehydrogenase. In the cytosol, GPD1 catalyzes this reaction, while GPD2 performs the same reaction in mitochondria. This reaction is reversible and is a key component of the glycerol-3-phosphate shuttle, which transfers reducing equivalents from the cytosol to the mitochondrial electron transport chain. In kidney cancer, cytosolic GPD is essential for lipid synthesis, and its loss impairs tumor growth. Similarly, GPD1L, a cytosolic isoform, supports G3P and triacylglycerol synthesis in hepatocellular carcinoma.
Synthesis via glycerol phosphorylation
In simple terms: The cell can also make glycerol-3-phosphate by adding a phosphate group to glycerol.
An alternative route for G3P production is the phosphorylation of glycerol by glycerol kinase (GK). This reaction consumes ATP and produces ADP. In mammals, glycerol kinase is highly expressed in liver, kidney, and adipose tissue, where it facilitates the utilization of glycerol released from lipolysis. In plants, glycerol-3-phosphate is synthesized by glycerol kinase and by the DHAP reduction pathway, and it is a precursor for glycerolipid biosynthesis. The relative contribution of these two routes depends on the tissue and metabolic state.
Role in lipid biosynthesis
In simple terms: Glycerol-3-phosphate is the starting material for making fats and membrane lipids.
Once produced, G3P is acylated by glycerol-3-phosphate acyltransferases (GPATs) to form lysophosphatidic acid, which is further acylated to phosphatidic acid, a key intermediate in the synthesis of triacylglycerols and phospholipids. In plants, GPATs are critical for cutin and suberin biosynthesis, and their activity affects lipid composition. In cancer cells, increased G3P production supports the high demand for membrane lipids during rapid proliferation.
Signaling functions of G3P
In simple terms: Glycerol-3-phosphate can also act as a signal that changes gene expression.
Beyond its role as a lipid precursor, G3P functions as a signaling molecule. In citrin deficiency, elevated G3P activates the transcription factor ChREBP, leading to increased FGF21 transcription and lipogenesis. In chronic kidney disease, G3P contributes to increased FGF23 production, which regulates phosphate homeostasis. Additionally, G3P accumulation triggers senescence by rewiring lipid metabolism, involving a homeostatic switch that causes G3P and phosphoethanolamine accumulation. These findings demonstrate that G3P is not merely a metabolite but also a regulator of cellular processes.
Key Genes Involved in GO:0046167 glycerol-3-phosphate biosynthetic process
The following genes encode enzymes and regulators directly involved in the glycerol-3-phosphate biosynthetic process and its downstream effects.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPD1 | Cytosolic glycerol-3-phosphate dehydrogenase; reduces DHAP to G3P | Key enzyme in the glycerol-3-phosphate shuttle; linked to ROS production and HIF-1α stabilization |
| GPD2 | Mitochondrial glycerol-3-phosphate dehydrogenase; oxidizes G3P to DHAP | Component of the shuttle; contributes to mitochondrial ROS and metabolic signaling |
| GPD1L | Cytosolic glycerol-3-phosphate dehydrogenase-like; supports G3P and TAG synthesis | Promotes tumor progression in hepatocellular carcinoma; potential therapeutic target |
| GK | Glycerol kinase; phosphorylates glycerol to G3P | Alternative route for G3P synthesis; important in liver and kidney metabolism |
| GPAT1 | Glycerol-3-phosphate acyltransferase 1; converts G3P to lysophosphatidic acid | Rate-limiting for glycerolipid synthesis; affects lipid storage and insulin sensitivity |
| GPAT2 | Glycerol-3-phosphate acyltransferase 2 | Involved in testis-specific lipid metabolism and cancer |
| GPAT3 | Glycerol-3-phosphate acyltransferase 3 | Plays a role in adipocyte lipid droplet formation |
| GPAT4 | Glycerol-3-phosphate acyltransferase 4 | Contributes to hepatic steatosis and lipid homeostasis |
| ChREBP | Transcription factor activated by G3P; induces FGF21 and lipogenic genes | Mediates G3P signaling in citrin deficiency |
| FGF21 | Hormone induced by ChREBP; regulates lipid and glucose metabolism | Downstream effector of G3P signaling; biomarker in metabolic disease |
| FGF23 | Hormone that regulates phosphate homeostasis; induced by G3P | Links G3P to chronic kidney disease and mineral bone disorder |
| HIF-1α | Hypoxia-inducible factor 1-alpha; stabilized by mitochondrial ROS from G3P shuttle | Connects G3P metabolism to immune cell function |
| PPARγ | Nuclear receptor; regulates lipid metabolism and adipogenesis | Potential mediator of G3P effects on gene expression |
| SREBP1 | Sterol regulatory element-binding protein 1; master regulator of lipogenesis | Coordinates lipid synthesis with G3P availability |
| ACSL1 | Acyl-CoA synthetase long-chain family member 1 | Provides acyl-CoA for G3P acylation |
| DGAT1 | Diacylglycerol O-acyltransferase 1; converts DAG to TAG | Final step of TAG synthesis using G3P-derived DAG |
| DGAT2 | Diacylglycerol O-acyltransferase 2 | Alternative TAG synthesis enzyme; linked to lipid droplet formation |
| MOGAT | Monoacylglycerol O-acyltransferase | Alternative pathway for TAG synthesis; interacts with G3P metabolism |
How Is glycerol-3-phosphate biosynthetic process Regulated?
The glycerol-3-phosphate biosynthetic process is regulated at multiple levels. Transcriptional control of GPD1 and GPD2 is influenced by nutrient availability and hypoxia, with HIF-1α playing a role in the hypoxic response. In citrin deficiency, G3P levels rise and activate ChREBP, which in turn upregulates lipogenic genes and FGF21. The pathway is also subject to feedback inhibition by downstream products such as phosphatidic acid and diacylglycerol. Hormonal signals, including insulin and glucagon, modulate glycerol kinase activity and GPD expression, thereby adjusting G3P production to meet the cell's lipid synthesis demands. Additionally, the glycerol-3-phosphate shuttle is regulated by the redox state of the cell, as it depends on the NAD+/NADH ratio.
glycerol-3-phosphate biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPD1L | Hepatocellular carcinoma; promotes tumor progression via G3P and TAG synthesis | GPD1L knockout and overexpression in HCC cell lines; xenograft mouse models |
| GPD1 | Kidney cancer; cytosolic GPD essential for lipid synthesis | GPD1 knockout in renal cancer cells; lipidomics and proliferation assays |
| ChREBP | Citrin deficiency; G3P activates ChREBP and FGF21 | ChREBP knockout in hepatocytes; G3P treatment and gene expression analysis |
| FGF23 | Chronic kidney disease; G3P increases FGF23 production | FGF23 reporter assays in osteocytes; G3P treatment |
| GPD2 | Neutrophil function; mitochondrial ROS via G3P shuttle stabilizes HIF-1α | GPD2 knockout in neutrophils; ROS and HIF-1α measurements |
Glycerol-3-phosphate biosynthetic process in cancer
Cancer cells often reprogram lipid metabolism to support rapid proliferation. In kidney cancer, cytosolic GPD is essential for lipid synthesis, and its inhibition reduces tumor growth. In hepatocellular carcinoma, GPD1L supports G3P and triacylglycerol synthesis and promotes tumor progression, suggesting that targeting this enzyme could be therapeutic. The glycerol-3-phosphate shuttle also contributes to mitochondrial ROS production, which can stabilize HIF-1α and promote adaptation to hypoxia in tumors. These findings underscore the importance of G3P biosynthesis in cancer metabolism.
Glycerol-3-phosphate biosynthetic process in metabolic disorders
In citrin deficiency, a metabolic disorder caused by mutations in SLC25A13, elevated G3P activates ChREBP and increases FGF21 transcription, leading to enhanced lipogenesis. This links G3P directly to the pathophysiology of the disease. Additionally, G3P accumulation triggers senescence by rewiring lipid metabolism, which may contribute to age-related metabolic dysfunction. In chronic kidney disease, G3P contributes to increased FGF23 production, which is associated with mineral bone disorder and cardiovascular complications. Thus, dysregulated G3P biosynthesis is a common feature of several metabolic conditions.
Glycerol-3-phosphate biosynthetic process in kidney disease
Chronic kidney disease (CKD) is characterized by elevated FGF23, which helps maintain phosphate balance but also contributes to left ventricular hypertrophy and mortality. Recent evidence shows that G3P contributes to the increase in FGF23 production in CKD. This suggests that targeting G3P biosynthesis or signaling could lower FGF23 and improve outcomes in CKD patients. Further research is needed to determine whether G3P-lowering therapies are beneficial in this context.
From glycerol-3-phosphate biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GPD1L reduce tumor growth in HCC? | GPD1L knockout in HCC cell lines and mouse xenografts |
| Does GPD1 deletion impair lipid synthesis in kidney cancer? | GPD1 knockout in renal cancer cells; lipidomics and proliferation assays |
| Does G3P activate ChREBP in citrin deficiency? | ChREBP knockout hepatocytes treated with G3P; RNA-seq and ChIP-seq |
| Does G3P regulate FGF23 production in CKD? | Osteocyte-like cells with G3P treatment; FGF23 ELISA and promoter assays |
| Does GPD2-derived ROS stabilize HIF-1α in neutrophils? | GPD2 knockout neutrophils; ROS measurement and HIF-1α Western blot |
| Does G3P accumulation trigger senescence? | GPD1 overexpression or knockdown in fibroblasts; senescence markers and lipidomics |
How to Study the glycerol-3-phosphate biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of glycerol-3-phosphate and other metabolites | Quantify G3P in cells with GPD1/GPD2 perturbations |
| Lipidomics | Glycerolipid and phospholipid species | Assess downstream effects of G3P pathway manipulation |
| RNA-seq | Global gene expression changes | Identify transcriptional responses to G3P accumulation |
| ChIP-seq | Transcription factor binding sites | Map ChREBP binding upon G3P treatment |
| Western blot | Protein expression and phosphorylation | Validate knockout or overexpression of GPD1L, GPD2 |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Discover novel regulators of G3P metabolism |
| Seahorse assay | Mitochondrial respiration and glycolysis | Measure metabolic flux via G3P shuttle |
| Senescence assays | SA-β-gal staining, proliferation arrest | Evaluate G3P-induced senescence |
Metabolomics and lipidomics
Mass spectrometry-based metabolomics allows direct quantification of glycerol-3-phosphate and related metabolites in cells and tissues. Lipidomics can profile the downstream glycerolipids and phospholipids. These methods are essential to confirm changes in G3P biosynthesis and to link them to specific gene perturbations.
Transcriptomics and ChIP-seq
RNA sequencing (RNA-seq) reveals global changes in gene expression upon modulation of G3P pathway genes. ChIP-seq can identify binding sites of transcription factors such as ChREBP that are activated by G3P. These approaches help uncover the signaling roles of G3P beyond its metabolic function.
Proteomics and immunoblotting
Western blotting and mass spectrometry-based proteomics are used to measure protein levels and post-translational modifications of enzymes like GPD1, GPD2, and GPD1L. These methods are critical for validating knockout or overexpression models.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes that are essential for G3P biosynthesis or that mediate its downstream effects. Such screens have been used to uncover metabolic vulnerabilities in cancer cells, including those related to lipid synthesis.
How CRISPR Can Be Used to Study GO:0046167 glycerol-3-phosphate biosynthetic process
Knockout
CRISPR-Cas9 knockout of GPD1, GPD2, or GPD1L can abolish specific routes of G3P biosynthesis, allowing researchers to determine their contribution to lipid synthesis, ROS production, and tumor growth. Knockout models are also useful to study compensatory mechanisms between cytosolic and mitochondrial pathways.
Point Mutation
Introducing point mutations in catalytic residues of GPD1 or GPD1L can dissect enzymatic activity from non-enzymatic functions. For example, mutation of the NAD+ binding site can render the enzyme inactive while preserving protein interactions. Such models help clarify the precise role of G3P in signaling versus biosynthesis.
Knock-in
Knock-in of tagged versions of GPD1 or GPD2 (e.g., FLAG or GFP) enables localization and interaction studies. Knock-in of disease-associated mutations, such as those found in GPD1L, can model human disorders in cell lines or mice. These models are valuable for understanding how specific mutations affect G3P levels and downstream phenotypes.
Overexpression
Overexpression of GPD1 or GPD1L increases G3P production and can drive lipid accumulation, senescence, or tumor progression. Overexpression models are useful to test sufficiency of G3P in activating signaling pathways such as ChREBP or FGF23. They also serve as positive controls in metabolic assays.
How EDITGENE Supports glycerol-3-phosphate biosynthetic process Research
Researchers studying glycerol-3-phosphate biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in G3P production, lipid metabolism, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for glycerol-3-phosphate biosynthetic process research.
Frequently Asked Questions About glycerol-3-phosphate biosynthetic process
What is glycerol-3-phosphate biosynthetic process?
It is the set of biochemical reactions that produce glycerol-3-phosphate, a key precursor for glycerolipids and a signaling molecule, defined by GO:0046167.
What genes are involved in glycerol-3-phosphate biosynthetic process?
Key genes include GPD1, GPD2, GPD1L, and glycerol kinase (GK), which catalyze the reduction of DHAP or phosphorylation of glycerol to form G3P.
How is glycerol-3-phosphate biosynthetic process regulated?
It is regulated by nutrient and hormonal signals, transcription factors like ChREBP, and feedback inhibition by downstream lipids.
What diseases are associated with glycerol-3-phosphate biosynthetic process?
Dysregulation is linked to cancer (e.g., hepatocellular carcinoma, kidney cancer), citrin deficiency, chronic kidney disease, and senescence.
What is the role of GPD1 in glycerol-3-phosphate biosynthesis?
GPD1 is the cytosolic glycerol-3-phosphate dehydrogenase that reduces DHAP to G3P, a key step in the glycerol-3-phosphate shuttle.
How does glycerol-3-phosphate affect lipid metabolism?
G3P serves as the glycerol backbone for triacylglycerol and phospholipid synthesis, and its availability can influence lipogenic gene expression.
Can CRISPR be used to study glycerol-3-phosphate biosynthetic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of G3P pathway genes to study their functions and disease roles.
What is the glycerol-3-phosphate shuttle?
It is a metabolic shuttle that transfers reducing equivalents from cytosolic NADH to mitochondrial FAD, involving GPD1 and GPD2, and contributes to ROS production.
How is glycerol-3-phosphate measured in cells?
It is typically measured by mass spectrometry-based metabolomics or by enzymatic assays, often combined with lipidomics to assess downstream effects.
Why is glycerol-3-phosphate important in cancer?
Cancer cells require G3P for membrane lipid synthesis, and enzymes like GPD1L and GPD1 support tumor growth, making them potential therapeutic targets.
Conclusion
The glycerol-3-phosphate biosynthetic process (GO:0046167) is a fundamental metabolic pathway that supplies the glycerol backbone for glycerolipid synthesis and also functions as a signaling hub. Its dysregulation is implicated in cancer, metabolic disorders, and kidney disease, underscoring its clinical relevance. Advances in CRISPR genome editing and multi-omics technologies now enable precise dissection of the pathway's components and their roles in health and disease. EDITGENE's suite of CRISPR services provides researchers with the tools needed to generate robust cell models and accelerate discoveries in this field.
References
- 1. Tighanimine K et al.. 2024. A homoeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism.. Nat Metab 6(2):323-342 PMID: 38409325
- 2. Tiwari V et al.. 2025. Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency.. Nat Metab 7(11):2284-2299 PMID: 41238906
- 3. Willson JA et al.. 2022. Neutrophil HIF-1α stabilization is augmented by mitochondrial ROS produced via the glycerol 3-phosphate shuttle.. Blood 139(2):281-286 PMID: 34411229
- 4. Yao CH et al.. 2023. Uncoupled glycerol-3-phosphate shuttle in kidney cancer reveals that cytosolic GPD is essential to support lipid synthesis.. Mol Cell 83(8):1340-1349.e7 PMID: 37084714
- 5. Chen X et al.. 2011. sn-Glycerol-3-phosphate acyltransferases in plants.. Plant Signal Behav 6(11):1695-9 PMID: 22057337
- 6. Simic P et al.. 2025. Glycerol-3-phosphate contributes to the increase in FGF23 production in chronic kidney disease.. Am J Physiol Renal Physiol 328(2):F165-F172 PMID: 39716914
- 7. Yu TC et al.. 2026. GPD1L supports glycerol-3-phosphate and triacylglycerol synthesis and promotes tumor progression in HCC.. Hepatology 83(4):735-752 PMID: 40344414
- 8. Velando F et al.. 2025. Chemoreceptor family in plant-associated bacteria responds preferentially to the plant signal molecule glycerol 3-phosphate.. Genome Biol 26(1):260 PMID: 40883827
